DOI: 10.1055/s-00000094

Zeitschrift für Gastroenterologie

References

Mitry E. et al.
Bevacizumab plus capecitabine in patients with progressive advanced well-differenziated neuroendocrine tumors of the gastro-intestinal (GI-NETs) tract (BETTER trial)--a phase II non-randomised trial.

Eur J Cancer 2014;
50: 3107-3115

Download Bibliographical Data

Search in:
Access: